
Ken Griffin’s Aprea Therapeutics APRE Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-30,083
| Closed | -$61.4K | – | 5809 |
|
2025
Q1 | $61.4K | Buy |
+30,083
| New | +$61.4K | ﹤0.01% | 5308 |
|
2023
Q1 | – | Sell |
-1,276
| Closed | -$411 | – | 5891 |
|
2022
Q4 | $411 | Buy |
+1,276
| New | +$411 | ﹤0.01% | 5960 |
|
2022
Q3 | – | Sell |
-18,881
| Closed | -$14K | – | 5840 |
|
2022
Q2 | $14K | Sell |
18,881
-58,201
| -76% | -$43.2K | ﹤0.01% | 5775 |
|
2022
Q1 | $143K | Sell |
77,082
-86,179
| -53% | -$160K | ﹤0.01% | 5477 |
|
2021
Q4 | $469K | Buy |
163,261
+41,312
| +34% | +$119K | ﹤0.01% | 4673 |
|
2021
Q3 | $623K | Buy |
121,949
+93,330
| +326% | +$477K | ﹤0.01% | 4293 |
|
2021
Q2 | $140K | Buy |
+28,619
| New | +$140K | ﹤0.01% | 5784 |
|
2021
Q1 | – | Hold |
0
| – | – | – | 6233 |
|
2020
Q4 | – | Sell |
-74,073
| Closed | -$1.78M | – | 5044 |
|
2020
Q3 | $1.78M | Sell |
74,073
-234,875
| -76% | -$5.65M | ﹤0.01% | 2384 |
|
2020
Q2 | $12M | Sell |
308,948
-12,293
| -4% | -$477K | ﹤0.01% | 993 |
|
2020
Q1 | $11.2M | Buy |
321,241
+12,229
| +4% | +$425K | 0.01% | 927 |
|
2019
Q4 | $14.2M | Buy |
+309,012
| New | +$14.2M | 0.01% | 987 |
|